✦ LIBER ✦

Phase II trial of menogaril (NSC 269148) in chemotherapy-naive patients with advanced squamous carcinoma of the cervix

✍ Scribed by G. Sutton; J. Blessing; D. Gallup; H. Homesley

Book ID: 119054354
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 165 KB
Volume: 45
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(92)90627-u

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of ifosfamide and mesna i

Phase II trial of ifosfamide and mesna in chemotherapy-naive patients with recurrent or advanced squamous carcinoma of the cervix

✍ G. Sutton; J. Blessing; W. McGuire; T. Patton 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase II Trial of Menogaril in Patients

Phase II Trial of Menogaril in Patients with Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

✍ Gregory P. Sutton; John A. Blessing; Rolland J. Barrett; Donald G. Gallup 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Phase II trial of vinblastine in patient

Phase II trial of vinblastine in patients with advanced or recurrent squamous carcinoma of the cervix

✍ G. Sutton; J. Blessing; D. Smith; W. Barnes 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Phase II evaluation of menogaril in pati

Phase II evaluation of menogaril in patients with advanced cervical carcinoma

✍ Harry J. Long; Harry S. Wieand; John F. Foley; Robert D. Niedringhaus; John A. L 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 170 KB

Fourteen patients with advanced/recurrent squamous cell carcinoma of the uterine cervix received menogaril, 200 mg/m 2 by one hour intravenous infusion at four-week intervals. No objective regressions were observed. Median time to progression was less than two months and median survival was seven mo

Negative phase II trial of menogaril in

Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung

✍ Joss, Rudolf A.; Monfardini, Silvio; Hansen, Mogens; Dombernowsky, Per; Renard, 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 286 KB

A Phase II trial of gemcitabine and doce

A Phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma

✍ Irina E. Popa; Kathleen Stewart; Frederick P. Smith; Naiyer A. Rizvi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Abstract ## BACKGROUND The goals of the current study were to determine the safety and efficacy of a nonplatinum‐containing doublet, gemcitabine and docetaxel, in the treatment of patients with chemotherapy‐naive nonsmall cell lung carcinoma (NSCLC). ## METHODS Thirty‐two patients with advanc